Eukaryotic proteins can be expressed in different heterologous systems. 7
Introduction 21
Heterologous expression of proteins is defined as the expression of proteins in an 22 organism that does not naturally express the protein. The different systems in use for such 23 purposes can be broadly classified as bacterial, yeast, insect and mammalian systems. Cells 24 in culture can be manipulated to express the protein of interest in transient or stable mode. 25 Some factors that need to be considered while choosing the expression system are the 26 required yield of the protein, post-translational modifications, functionality, and speed of 27 expression. 28
Proteins of prokaryotic origin are best expressed in bacterial systems. E. coli can express 29 and adequately process prokaryotic proteins and is the go-to system for cheap, scalable and 30 high yield expression. If the expression of eukaryotic proteins is required, additional factors 31 need to be taken into consideration. The most important factor would arguably be the level 32 of post-translational modifications (PTM) required for a functional form of the protein. 33 Proteins requiring extensive PTMs will not be processed correctly in bacterial systems and 34 will most likely aggregate in inclusion bodies [1] - [3] . Adding a fusion protein tag to the 35 protein of interest may sometimes help to resolubilize the proteins. However, in the interest 36 of saving time and effort, it is advisable to switch to higher eukaryotic systems such as insect 37 or mammalian cells. Another advantage to eukaryotic systems is the presence of extensive 38 protein folding machinery that is vital for the function of the protein [4]. 39 Table 1 compares the different heterologous protein expression systems with respect to 40 the type of protein, post-translational modifications and ease of large-scale production [5]-41 [10] . 42 43 44 45 Bacterial systems have desirable characteristics for large scale production but are not 52 able to process and correctly fold proteins requiring extensive PTMs [11] . Depending on the 53 application of the protein, Chinese hamster ovary (CHO) or Human embryonic kidney (HEK 54 293) cells are typically the system of choice for eukaryotic proteins [12] . This is true, 55 especially for therapeutic proteins or antibodies. However, the yield is very low compared to 56 insect or bacterial cells -typically on the order of 100mg/L of expressed protein [13] . The 57 level of protein expression is higher in insect cells up to 100mg/ L [14] , [15] . 58 Insect cells and mammalian systems have a wide range of post-translational 59
modifications. An excellent tool to determine all possible post-translational modifications of 60 a protein of interest is dbPTM (http://dbptm.mbc.nctu.edu.tw/). Insect and mammalian 61 systems are both capable of all PTMs with one exception. Insect cells and mammalian cells 62 have similar phosphorylation and O-linked glycosylation patterns. They can authentically 63 process phosphorylation modifications, partly due to the presence of phosphatases. However, 64
in terms of N-glycosylation, proteins in insect cells are high-mannosylated while mammalian 65 cells have a complex glycosylation pattern [4], [12] . Figure 1 depicts the difference in N-66 linked glycosylation patterns in insect cells vs. mammalian cells. Regular insect Sf9 and Sf21 67 cells will have a high mannose pattern of glycosylation but mimic Sf9 (available from 68
ThermoFisher) cells are engineered to make complex N-glycans with terminal sialic acid. 69
Varied and complex sugars such as N-acetylneuraminic acid, galactose, fucose, mannose are 70 added in mammalian cells in a branched configuration as opposed to the addition of only 71 mannose residues in insect cells. 72 However, there are no detailed methods or protocol papers published for this procedure, that 89 is, using the Sf9 cells and 6X His tag method. 90
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Post-translational modifications for IRE1 were predicted using algorithms developed by 91
the Center for Biological Sequence Analysis, Technical University of Denmark (http://www. 92 cbs.dtu.dk/ [1] . The predicted N-glycosylation, O-glycosylation, C-mannosylation and 93 glycation sites are scored for the likelihood of modification ( Table 2 ). The scores that cross 94 the threshold (which is set by the algorithm at 0.5) are denoted as "positive" hits. 95 96 IRE1α-CD in Sf21 cells using baculoviral vectors. The procedure is divided into 5 subunits. 152
The time required for each subunit is indicated in brackets in the left column (Figure 2) . 
Cloning of IRE1α-CD into pFastBac plasmid 157
Note: 158 pFastBac His6 MBP N10 TEV LIC cloning vector (4C) was a gift from Scott Gradia 159 (Addgene plasmid #30116; http://n2t.net/addgene:30116; RRID: Addgene_30116). Another 160 version of this plasmid (5C) is available so that two proteins can be expressed simultaneously. 161
The sequence for IRE1α-CD was obtained from NCBI (Gene id: 2081). Primers were 162 designed to clone the CD fragment from 547 aa-977 aa from a pCDNA-hIRE1 plasmid 163 containing a full-length IRE1 coding sequence. 164 165
Table 4: PCR primers for insertion of IRE1-CD (547aa-977aa) into pFastBac plasmid 166
CD_IRE1_forward 5'-TACTTCCAATCCAATGCAGGCAGCAGCCCCTCCCTGGAAC-3'
167 Table 4 shows the primers designed for the insertion of IRE1α-CD into the empty 168 pFastBac plasmid. The underlined tag on each primer is to facilitate ligation independent 169 cloning (LIC) and is specific to the pFastBac backbone. The rest of the primer is specific to 170 the insert coding sequence (CDS iii.
To create pFastBac vector overhangs, mix the following components in PCR tubes, 184
the order of addition is as listed (T4 DNA polymerase is added last) ( Table 6) . 185 Incubate at 12 o C for 30 minutes followed by heat inactivation at 75 o C for 20 minutes. 186 187 189
Preparing the insert IRE1α-CD 190 iv. Set up a PCR to amplify the IRE1α-CD insert using the primers in Table 4 as outlined  191 in Table 7 . Confirm amplification by running the PCR product on a 1.5% agarose 192 gel. 193 iii. Add all the antibiotics and chemicals in the working concentrations listed in Table 8 . 230 231 ix.Add 5 CV of elution buffer at a reduced flow rate of 0.5 mL/min, and assay elute fractions 341
to determine fractions with the highest concentration of the protein of interest with a 342
Bradford or BCA assay. 343
x.Regenerate the column with 3 CV distilled water followed by 3 CV of 0.5 M NaOH. 344
Wash away the NaOH with 5 CV distilled water. The column is now ready to be used 345 again. 346 347
Expected Results 348
The pFastBac-IRE1α-CD plasmid features are shown in Figure 3 After this additional round of selection, a colony PCR was performed to make sure that 362
IRE1α-CD was incorporated into the recombinant bacmid (Figure 4) . Primers specific to an 363 internal region in IRE1α-CD were used. As expected, a band was seen in all of the white 364 colonies picked, indicating that the gene of interest was inserted in the bacmid. Bacmids were 365 prepped and sent for DNA sequencing. Once the IRE1α-CD sequence was confirmed, 366 glycerol stocks were made for future use (see We checked the expression of IRE1α-CD after transfection by collecting cell lysate after 383 P0 and P1 infections. Figure 6 shows a GelCode Blue-stained SDS-PAGE (8%) of cell 384 lysates after transfection and infection with baculoviruses to express IRE1α-CD. As evident 385 in the figure, the IRE1α-CD protein is produced along with other contaminating insect cell 386 proteins, also stained by GelCode Blue and therefore needs to be purified for downstream 387 assays. The proportion of IRE1α-CD protein expressed in P1 infected cells was more than 388 P0 infected cells, reflecting the higher concentration of baculoviral titer. The baculovirus 389 stock was amplified to P3 to obtain high protein expressing infected Sf21 cells. 390
The P3 viral supernatant was collected, filtered with a 0.22 µm filter and stored at 4 o C 391
in the dark for subsequent infection. Sf21 cells were passaged the day before infection so that 392 they were in log phase at a density of 3x10 5 cells/mL. 150 µL of P3 supernatant was added 393
for Bio-Rad, cat# 1610373) . The E2 428 fraction shows a pure protein band at ~100kDa as expected 429 430
Sf21 insect cells combined with the pFastBac baculoviral system make a very robust, 431
optimizable system for expression of eukaryotic proteins. MBP-IRE1α-CD was successfully 432 expressed and purified from Sf21 cells. This protocol can be easily modified to express any 433 mammalian protein in Sf21 insect cells by modifying the PCR primers shown in technique in conjunction with a Phos-tag gel would lend more information on the ratio of 447 phosphorylated to unphosphorylated species in the purified protein [23] , [24] . Using the Phos-448 tag ligand developed by Fujifilm Wako-Chem, an SDS-PAGE gel can be used to separate 449 phosphorylated proteins from unphosphorylated forms. The Phos-tag ligand binds to the 450 phosphate group and slows down migration of the phosphorylated band. This leads to a 451 separation of the phosphorylated and unphosphorylated species into separate bands. To 452 confirm that the band pattern is because of distinct phosphorylation, purified protein samples 453
can be treated with λ-phosphatase enzyme with activity towards phosphorylated serine, 454 threonine and tyrosine residues. On treatment and subsequent application to a Phos-tag SDS-455 PAGE gel, the slower migrating band should disappear. In vitro XBP1 splicing can be 456 assayed with a hairpin-RNA cleavage assay or by a fluorescence-based assay with a FRET-457 paired oligonucleotide [18] . 458
If the protein structure needs to be determined, circular dichroism or small-angle X-459 ray scattering techniques can be used. Circular dichroism is a very useful tool to determine 460 secondary structure as well as native folding of expressed or fusion proteins. Specifically, 461 secondary structure can be determined using far-UV spectra and protein folding 462 characteristics can be determined by monitoring spectra at different temperatures or in the 463 presence of different denaturing agents 
